Archives of Industrial Biotechnology

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (629)348-3199

Editorial - Archives of Industrial Biotechnology (2025) Volume 9, Issue 1

CRISPR and Genome Editing in Industrial Microorganisms.

Sarah Chang *

Department of Microbial Biotechnology, Pacific University of Science and Technology, United States

*Corresponding Author:
Sarah Chang
Department of Microbial Biotechnology, Pacific University of Science and Technology, United States
E-mail: sarah.chang@pust.edu

Received: 09-Feb-2025, Manuscript No. AAAIB-25-163009; Editor assigned: 10-Feb-2025, PreQC No. AAAIB-25-163009; Reviewed:22-Feb-2025, QC No. AAAIB-25-163009; Revised:24-Feb-2025, Manuscript No. AAAIB-25-163009(R); Published:28-Feb-2025, DOI:10.35841/ aaaib -9.1.248

Citation: Chang S. CRISPR and Genome Editing in Industrial Microorganisms. J Micro Bio Curr Res. 2025;9(1):248

Visit for more related articles at Archives of Industrial Biotechnology

Introduction

The advent of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has revolutionized genome editing in both academic research and industrial biotechnology. In the context of industrial microorganisms, CRISPR has enabled precise and efficient modification of microbial genomes, allowing for the development of strains with enhanced productivity, resistance to stress, or the ability to synthesize novel compounds. This breakthrough technology has empowered scientists and industries to rapidly engineer microorganisms for a wide range of applications, including biofuel production, pharmaceuticals, and food processing. This article explores how CRISPR and genome editing are transforming the use of microorganisms in industrial biotechnology [1].

CRISPR-Cas systems, originally discovered as part of the bacterial immune system, have been harnessed as powerful tools for genome editing. The system relies on the Cas9 enzyme, guided by a short RNA sequence (guide RNA), to target and cut specific DNA sequences in the genome. Once the DNA is cut, the cell’s natural repair mechanisms are triggered, which can be exploited to either disrupt a gene (gene knockout) or introduce new genetic material (gene insertion). CRISPR's precision, simplicity, and cost-effectiveness have made it the most popular method for genome editing, significantly advancing the field of industrial biotechnology [2].

Industrial microorganisms such as bacteria, yeast, and fungi are the workhorses of biotechnology. These organisms are used in the production of a wide variety of industrial products, including biofuels, enzymes, pharmaceuticals, and food ingredients. Historically, these microorganisms have been improved through traditional mutagenesis or genetic engineering techniques. However, these methods were often slow, inefficient, and imprecise. CRISPR has changed the game by allowing for targeted, high-precision modifications to microbial genomes, enabling the development of optimized strains with enhanced capabilities for industrial applications [3].

One of the most important applications of CRISPR in industrial biotechnology is strain improvement. Industrial microorganisms are often subjected to harsh conditions, such as high temperatures, acidic or basic environments, and toxic chemicals. CRISPR allows for the precise editing of genes responsible for stress resistance, enabling microorganisms to better survive and thrive under industrial conditions. For example, CRISPR has been used to modify yeast strains to improve their tolerance to ethanol during biofuel production, resulting in higher yields and more efficient fermentation processes [4].

CRISPR also allows scientists to reprogram the metabolic pathways of microorganisms, optimizing them for the production of desired compounds. By knocking out genes that lead to the production of unwanted byproducts or by introducing new metabolic pathways, CRISPR can be used to direct more cellular resources toward the synthesis of valuable products. For instance, in the production of bio-based chemicals like succinic acid, CRISPR can be employed to disrupt competing pathways that consume the precursors needed for target product formation. This results in increased product yield and reduced waste [5].

CRISPR technology is closely intertwined with the field of synthetic biology, which seeks to design and construct new biological parts, devices, and systems. In industrial microorganisms, CRISPR has enabled the construction of synthetic pathways that do not naturally exist in these organisms. This allows microbes to produce novel compounds, such as new antibiotics, biofuels, or specialty chemicals. By combining CRISPR with other tools of synthetic biology, scientists can create "designer" microorganisms that are tailored to produce a wide range of industrially relevant products, thus expanding the scope of microbial biomanufacturing [6].

One of the key advantages of CRISPR is its ability to facilitate high-throughput genome editing, which is essential for industrial applications where multiple traits need to be optimized simultaneously. CRISPR libraries, which contain thousands of guide RNAs targeting different genes, allow for the simultaneous editing of multiple genes in a population of microorganisms. This approach enables rapid screening of large numbers of genetic variants to identify those that perform best under industrial conditions. High-throughput screening using CRISPR has already been employed in industries like biofuels and pharmaceuticals to identify strains with improved productivity [7].

The production of biopharmaceuticals, such as insulin, monoclonal antibodies, and vaccines, relies heavily on microbial expression systems. CRISPR has been instrumental in improving these systems by optimizing microbial host strains to increase the yield and quality of biopharmaceutical products. In particular, CRISPR has been used to delete genes associated with undesired protein glycosylation patterns or to enhance protein folding pathways in microbial cells. These modifications improve the efficiency of protein production and ensure that the final product has the desired structural and functional characteristics, meeting the stringent standards of the pharmaceutical industry [8].

CRISPR is also being used to engineer microorganisms for food and agricultural applications. In the food industry, microbes are used to produce enzymes, flavors, and preservatives. CRISPR enables the precise modification of these microorganisms to enhance their efficiency, improve the safety of food additives, or enable the production of novel ingredients. Additionally, CRISPR is being used to engineer probiotics with enhanced health benefits, such as strains of Lactobacillus or Bifidobacterium with improved gut health effects. In agriculture, CRISPR-modified microorganisms can be employed to promote plant growth, protect crops from pests, or increase nutrient availability in the soil [9].

While CRISPR offers significant advantages in genome editing, there are ethical and regulatory considerations that need to be addressed, particularly when editing organisms used in industrial applications. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Food Safety Authority (EFSA) are still developing frameworks to ensure the safe use of CRISPR-modified microorganisms. One of the key concerns is ensuring that modified strains do not have unintended effects on the environment or human health. Rigorous testing and validation are required to ensure that genome edits are stable and do not lead to off-target effects [10].

Conclusion

CRISPR technology has fundamentally changed the landscape of genome editing in industrial microorganisms. Its ability to precisely and efficiently edit microbial genomes has opened up new possibilities for strain improvement, metabolic engineering, and synthetic biology. As CRISPR continues to advance, it will play a central role in optimizing microorganisms for industrial applications, making processes more efficient, cost-effective, and environmentally friendly. With its vast potential, CRISPR is poised to revolutionize industrial biotechnology in the years to come

References

  1. Clare DA, Catignani GL, Swaisgood HE. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr Pharm Des. 2003;9(16):1239-55.

    2. Indexed at, Google Scholar, Cross Ref

  2. Coohill TP, Sagripanti JL. Overview of the inactivation by 254 nm ultraviolet radiation of bacteria with particular relevance to biodefense. Photochem Photobiol. 2008;84(5):1084-90.

    3. Indexed at, Google Scholar, Cross Ref

  3. Sergeev N, Distler M, Courtney S, et al. Multipathogen oligonucleotide microarray for environmental and biodefense applications. Biosens Bioelectron. 2004;20(4):684-98.

    4. Indexed at, Google Scholar, Cross Ref

  4. Petro JB, Plasse TR, McNulty JA. Biotechnology: Impact on biological warfare and biodefense. Biosecurity and Bioterrorism: Biodefense Strategy Practice and Science. 2003;1(3):161-8.

    5. Indexed at, Google Scholar, Cross Ref

  5. Jeddeloh JA, Fritz DL, Waag DM, et al. Biodefense-driven murine model of pneumonic melioidosis. Infection and immunity. 2003;71(1):584-7.

    6. Indexed at, Google Scholar, Cross Ref

  6. Boopathy R. Factors limiting bioremediation technologies. Bioresour Technol. 2000;74(1):63-7.

    7. Indexed at, Google Scholar, Cross Ref

  7. Watanabe K. Microorganisms relevant to bioremediation. Curr Opin Biotechnol. 2001;12(3):237-41.

    8. Indexed at, Google Scholar, Cross Ref

  8. Iwamoto T, Nasu M. Current bioremediation practice and perspective. J Biosci Bioeng. 2001;92(1):1-8.

    9. Indexed at, Google Scholar, Cross Ref

  9. Atlas RM. Bioremediation of petroleum pollutants. Int Biodeterior. 1995;35(1-3):317-27.

    10. Google Scholar, Cross Ref

  10. Pieper DH, Reineke W. Engineering bacteria for bioremediation. Curr Opin Biotechnol. 2000;11(3):262-70.

    11. Google Scholar, Cross Ref

Get the App